|
Agency Activities
In 1993, President Clinton
signed legislation providing for three CFIDS-specific entities at the National
Institutes of Health (NIH). Enforcement of these important provisions, part of
the NIH Reauthorization Act, marked the beginning of the Association's work with
federal health agencies to improve government CFS programs. Today the
Association's work extends beyond the NIH and Centers for Disease Control and
Prevention (CDC), the nation's largest federal biomedical research
organizations, to include numerous health, research, and service organizations.
Overview of
Activities The Association maintains active dialogue and, in some cases,
strategic partnerships with several federal agencies. Listed below are those
agencies with which the Association is most actively engaged:
Expanding the total funds
granted to CFIDS researchers and educators, ensuring accountability for funds
spent, improving responsiveness to CFIDS patients' needs, and guiding future
programs are the primary objectives of the Association's agency-related
activities.
The DHHS oversees the funding and programs of all the federal
health agencies, including NIH, CDC, HRSA and FDA. Secretary for Health Michael
Leavitt and Assistant Secretary John Agwunobi are directly involved in
management and oversight. DHHS has an advisory committee on CFS, the
CFSAC.
A clear understanding of the
mission and capacities of individual agencies is the foundation for our work.
Presently, CFIDS research funds are granted to academic researchers by NIH, CDC,
and NIDRR; CFIDS research is also conducted by CDC scientists and contractors.
SSA determines public disability policy, provides financial assistance to
qualified disabled persons, and has sponsored disability-related research on
CFS. HRSA is charged with improving distribution of health care services
across the U.S. and is responsible for many maintaining many vital social
service programs. The FDA regulates pharmaceutical development and approval and
DOL hears employment disputes, which sometimes involve injustices related to
disability arising from CFIDS.
The CFIDS-related activities
of these agencies, and others, warrant oversight by the Association and
individual advocates. Establishing and maintaining productive relationships with
key decision-makers in each agency is paramount to the success of these efforts.
However, diplomacy and compromise give way to more aggressive tactics when
required to protect vital CFIDS interests. Meetings of the
Chronic Fatigue Syndrome Advisory Committee
provide the opportunity to meet with agency officials in a public forum,
gather information about agency programs, and to document commitments in an
official written record. This committee exists to improve the utilization of
federal resources to meet the challenges that CFIDS brings; it is also charged
with coordinating federal efforts.
Recent
Accomplishments Numerous important strides have been made for the CFIDS
community through the Association's efforts to work with federal health
agencies. Among the most important recent achievements are the following:
-
Publication of an SSA Ruling designating CFS as a
potentially disabling condition, which has greatly improved access to
Social Security disability benefits for
eligible CFIDS patients
-
Exposing CDC funding
scandal and securing restoration of $12.9 million to CDC's CFS
program
-
Issue of a $4 million
Request for Applications by the
NIH to stimulate interest in CFS research by senior investigators and
young researchers.
Learn More About
Our Work with Federal Health Agencies
The CFIDS Chronicle,
mailed quarterly to Association
members reports on the Association's current activities with federal
agencies. You can find these reports in the "DC Dispatch" feature in
each issue. CFS-related information prepared by each agency is sometimes
available on that agency's Web site.
|